About Pulmonary Fibrosis Efficacy Safety Expert View Mechanism of Action Dosage RA-ILD risk calculator Previous Next Read more Read more Previous Play Next ILD in SSc & when to consider treatment by Dr. E. Volkmann 16/02/2024 | Author: Boehringer Ingelheim Document ID: EM-SG-100106 About Pulmonary Fibrosis A1-R101||A2-R101||How to recognize pulmonary fibrosis on HRCT scans (Rheum) A1-R101||A2-R101||Time is of the essence: Suspect fibrotic interstitial lung disease A1-R101||A2-R101||ILD in SSc & when to consider treatment by Dr. E. Volkmann A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann A1-R101||A2-R101||Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann A1-R101||A2-R101||Identifying ILD in patients with RA by Dr. Anna Hoffman-Vold A1-R101||A2-R101||RA-ILD DELPHI CONSENSUS SCREENING ALGORITHM A1-R101||A2-R101||How to identify patients with RA-ILD who can benefit from OFEV FSIN||How to recognize ILD in PPF patients with CTD Listen to our experts share their thoughts on what PF-ILD is and the high unmet need surrounding this disease Listen to our experts explain the importance of proactive monitoring in patients with ILD SGOFV2023COM||Vigilance and proactivity are critical in reducing the burden of disease SGOFV2023COM||Regular screening is critical as ILD can develop early Risk of acute exacerbations Lung function decline Pathophysiology of Pulmonary Fibrosis in ILD RELATED CONTENT Read more PDF A1-R101||A2-R101||How to recognize pulmonary fibrosis on HRCT scans (Rheum) Download Opens in new tab Read more PDF A1-R101||A2-R101||Time is of the essence: Suspect fibrotic interstitial lung disease Download Opens in new tab Read more 3:57 A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann Watch now Opens in new tab Read more 1:43 A1-R101||A2-R101||Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann Watch now Opens in new tab Read more 4:17 A1-R101||A2-R101||Identifying ILD in patients with RA by Dr. Anna Hoffman-Vold Watch now Opens in new tab Read more PDF A1-R101||A2-R101||RA-ILD DELPHI CONSENSUS SCREENING ALGORITHM Download Opens in new tab Pagination Load more Home Inflammation Nintedanib About Pulmonary Fibrosis A1-R101||A2-R101||ILD in SSc & when to consider treatment by Dr. E. Volkmann
Read more PDF A1-R101||A2-R101||How to recognize pulmonary fibrosis on HRCT scans (Rheum) Download Opens in new tab
Read more PDF A1-R101||A2-R101||Time is of the essence: Suspect fibrotic interstitial lung disease Download Opens in new tab
Read more 3:57 A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann Watch now Opens in new tab
Read more 1:43 A1-R101||A2-R101||Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann Watch now Opens in new tab
Read more 4:17 A1-R101||A2-R101||Identifying ILD in patients with RA by Dr. Anna Hoffman-Vold Watch now Opens in new tab
Read more PDF A1-R101||A2-R101||RA-ILD DELPHI CONSENSUS SCREENING ALGORITHM Download Opens in new tab